In the benign cohort, initial biopsies showed 37% of patients had ASAP with or without high-grade prostatic intraepithelial neoplasia (HGPIN), while 28% had HGPIN only, and 52% had neither ASAP or ...

New data show improved outcomes in resectable pancreatic cancer with PAXG chemotherapy over standard mFOLFIRINOX, but should ...

Adding atezolizumab to standard adjuvant chemotherapy significantly delayed recurrence or death for individuals with stage ...

DelveInsight’s Natural Killer (NK)-Cell Lymphoma Pipeline report depicts a robust space with 100+ active players working to develop 140+ pipeline therapies for Natural Killer (NK)-Cell Lymphoma ...

EBC-129 has been granted FDA fast track designation for the treatment of pancreatic ductal adenocarcinoma, paving the way for ...